Navigation Links
Elbit Imaging Announces the Results of the Company's Unsecured Financial Creditors Meeting Approving the General Terms of Agreement to be Entered Into With Bank Hapoalim
Date:11/26/2013

TEL AVIV, Israel, November 26, 2013 /PRNewswire/ --

Elbit Imaging Ltd. (the "Company") (TASE, NASDAQ: EMITF) announced today, further to the Company's announcement on November 14, 2013 (the "Previous Announcement"), the results of the meeting (the "Meeting") of the Company's unsecured financial creditors that voted on the general terms of agreement to be entered into with Bank Hapoalim B.M.  (the "Bank") as described in the Previous Announcement (the "Proposed Refinancing").

As noted in the Previous Announcement, the adjusted plan of arrangement which was approved by creditors representing approximately 97% of the unsecured financial debt of the Company (the "Arrangement") includes, among other things, a condition precedent (the "Condition Precedent") that an understanding, approved by holders holding more than 50% of the aggregate voting power participating in a meeting of the unsecured financial creditors (excluding abstentions), will be reached between the Company and the Bank.

At the Meeting, unsecured financial creditors holding approximately 70.6% of the aggregate voting power that have participated in the Meeting, voted in favor of the Proposed Refinancing and accordingly the approvals or consents of the unsecured financial creditors as required for the fulfillment of the Condition Precedent have been obtained.

The Arrangement remains subject to the approval of the Court and such other conditions described in the Company's Proxy Statement dated July 16, 2013 and in the Company's press release dated September 18, 2013.

About Elbit Imaging Ltd.

Elbit Imaging Ltd. operates in the following principal fields of business: (i) Commercial and Entertainment Centers - Initiation, construction and sale of shopping and entertainment centers and other mixed-use real property projects, predominantly in the retail sector, located in Central and Eastern Europe and in
'/>"/>

SOURCE Elbit Imaging Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Elbit Imaging Ltd. Announces Results of its General Meeting
2. Elbit Imaging Ltd. Announces (1) Courts Resolution Regarding the Results of Creditors Meeting and (2) Results of Extraordinary General Meeting
3. Elbit Imaging Ltd. Announces First Quarter Results For 2013
4. Elbit Imaging Announces the Court Decision with Respect to Filing of Plan of Arrangement with the Israeli Court
5. Elbit Imaging Announces Receipt of an Acceleration Notice from Bank Leumi
6. Elbit Imaging Reaches an Understanding Regarding a Proposed Debt Restructuring
7. Elbit Imaging to Suspend Interest Payments to All Note Holders
8. Elbit Imaging Ltd. Announces InSightecs ExAblate Neuro System Awarded European CE Mark for Non-invasive Treatment of Neurological Disorders in the Brain
9. Elbit Imaging Ltd. Announces Standard & Poors Maalot Changes Rating of Companys Notes
10. Elbit Imaging Ltd. Announces Second Quarter Results for 2012
11. German Experts Present Medical Imaging Advances at RSNA 13
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... SPARTANBURG , Carolina del Sur , ... Nueva colaboración para ampliar drásticamente el acceso al ... los Estados Unidos   La ... los pacientes con cáncer apoyo de decisión clínica ... y Molecular Health han anunciado una colaboración diseñada ...
(Date:5/30/2015)... 30, 2015  Eisai Inc. announced today the results of ... met the study,s primary endpoint evaluating overall survival in patients ... types of advanced soft tissue sarcoma. These data will be ... American Society of Clinical Oncology (ASCO) in Chicago ... Saturday, May 30, and also in an oral session on ...
(Date:5/30/2015)... 2015 Caris Life Sciences®, a leading ... precision medicine, today announced the presentation of data ... Caris Molecular Intelligence®, the company,s panomic comprehensive tumor ... share histological features. In separate presentations at the ... Oncology (ASCO) in Chicago, Ill. ...
Breaking Medicine Technology:Nueva colaboración para ampliar el acceso al ensayo clínico terapéutico para pacientes con cáncer en EEUU 2Nueva colaboración para ampliar el acceso al ensayo clínico terapéutico para pacientes con cáncer en EEUU 3Nueva colaboración para ampliar el acceso al ensayo clínico terapéutico para pacientes con cáncer en EEUU 4Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 2Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 3Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 4Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 5Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 6Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 2Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 3Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 4Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 5Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 6
... - Initial clinical trial results suggesting safety and ... the AACR-NCI-EORTC International Conference -, BRANFORD, Conn., ... a clinical-stage biopharmaceutical company focused on,oncology, announced that ... CR011-,vcMMAE, an antibody-drug conjugate (ADC) being developed for ...
... of Two Major Clinical Studies TAX 323 and ... Sanofi-aventis,announced today that results of two clinical ... to cisplatin and,5- fluorouracil for induction therapy, significantly ... squamous cell carcinoma of,the head and neck (SCCHN) ...
Cached Medicine Technology:CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma 2CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma 3CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma 4CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma 5CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma 6Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 2Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 3Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 4Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 5Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 6Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 7
(Date:5/30/2015)... 30, 2015 Nicole Blodgett, Vice ... Income Associate (DIA) designation to further her expertise ... is designed for insurance advisors, health care professionals, ... knowledge and expertise associated with the risk and ... designation is only the latest accomplishment in Nicole's ...
(Date:5/30/2015)... 30, 2015 Cyclist Barry Haarde ... for the World 2015: Piles of Miles” near ... awareness about hemophilia and encourage individuals to support ... , Save One Life supports nearly 1,200 impoverished ... countries through direct sponsorships, scholarships and micro-enterprise grants. ...
(Date:5/30/2015)... CA (PRWEB) May 30, 2015 Key ... California, is proud to announce their June 2015 featured ... apartment community in San Francisco, Key Housing is helping ... housing in what is one of the tightest apartment ... a plum posting, and understandably anyone who requires temporary ...
(Date:5/30/2015)... “ Milli the Snail ” was featured on ... look at the latest and coolest applications on the market ... AppWatch and technology expert, conducted the app review and shared ... and educates children. , Interactive mobile games for children have ... and games they are playing are doing much for their ...
(Date:5/30/2015)... York, NY (PRWEB) May 30, 2015 ... Wednesday, May 26th 2015, announcing that, “criminals used taxpayer-specific ... to information on approximately 100,000 tax accounts through IRS’ ... date of birth and street address.” , “You ... industry to have to think it was only a ...
Breaking Medicine News(10 mins):Health News:Secura Consultants Expands Disability Insurance Expertise 2Health News:Barry Haarde Cycles 4,000 Miles Across the USA for Hemophilia 2Health News:San Francisco Corporate Housing Leader Key Housing Designates 388 Beale Street as Featured Community for June 2Health News:San Francisco Corporate Housing Leader Key Housing Designates 388 Beale Street as Featured Community for June 3Health News:An Aesthetic Game that Engages and Educates Children was Featured on NewsWatch Television 2Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 2Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 3Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 4Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 5
... , PLAINVIEW, N.Y., July 17 Davis Vision, Inc., ... has already provided more than $200,000 to date in free vision ... exams and eyeglasses have been provided to more than 1,500 people ... bring our ,Focus on America, vision program to a variety of ...
... , WORCESTER, Mass., July 17 The ... property and casualty insurer, today announced the availability of a new product ... in assisted living facilities. , , ... , The coverage is more important than ever ...
... , , SKILLMAN, N.J., July ... technologies for community and hospital care, announced today it received first ... Advertising Effectiveness Awards for its Flexi-Seal((R) )Fecal Management System (FMS). ... Flexi-Seal((R)) FMS, a temporary containment device for patients with acute fecal ...
... , , HARTFORD, Conn., July 17 ... summer have more opportunities for hands-on, minds-on exploration and fun thanks ... , , Issued earlier this year, ... & crafts and athletic activities, to add new resources and programs ...
... journal- , , BELLEVILLE, ON, July 17 /PRNewswire-FirstCall/ ... technology-driven Canadian biopharmaceutical company, today announced that the results ... Company,s Escherichia coli (E. coli) O157 vaccine - Econiche(TM) ... Foodborne Pathogens and Disease (Vol. 6, Number 7, 2009), ...
... and for profit collaborate during tough economic times , ... sinking economy are thinking out of the box these days. In ... the same way except that their funding comes not from donors but ... Jungle Island decided to collaborate to attract patrons to visit the animal ...
Cached Medicine News:Health News:Davis Vision Provides More Than $200,000 in Free Vision Care Services 2Health News:Davis Vision Provides More Than $200,000 in Free Vision Care Services 3Health News:The Hanover Launches New Insurance Option to Protect Family Members in Assisted Living Facilities 2Health News:The Hanover Launches New Insurance Option to Protect Family Members in Assisted Living Facilities 3Health News:Flexi-Seal(R) Fecal Management System Receives 2008 Critical Care Nurse Advertising Effectiveness Award 2Health News:Flexi-Seal(R) Fecal Management System Receives 2008 Critical Care Nurse Advertising Effectiveness Award 3Health News:Hartford's Camp Courant Gets a 'Brick' Up on Summer Thanks to $100,000 Grant From The LEGO(R) Children's Fund 2Health News:Hartford's Camp Courant Gets a 'Brick' Up on Summer Thanks to $100,000 Grant From The LEGO(R) Children's Fund 3Health News:Econiche(TM) Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 2Health News:Econiche(TM) Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 3Health News:Econiche(TM) Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 4Health News:Econiche(TM) Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 5Health News:Econiche(TM) Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease 6Health News:Fundraising in the Jungle 2
ACMI™ COAG Bipolar Laparoscopy Probes provide 360 of hemostatis, bipolar safety, blunt dissection, irrigation, and suction in one instrument....
... vitro Nucleic Acid Hybridization Assay ... Chemiluminescence for the Qualitative Detection ... 6,11,16,18,31,33,35,39,42,43,44,45,51,52,56,58,59 and 68 and Analysis ... Groups in Cervical Specimens: HPV ...
An In Vitro Nucleic Acid Hybridization Assay with Signal Amplification using Microplate Chemiluminescence for the Qualitative Detection of Human Papillomavirus (HPV) Types 16, 18, 31, 33, 35, 39, 45,...
... AS100 Analyzer is designed ... regardless of the sample ... launched in December 2004, ... in May 2005. Assays ...
Medicine Products: